Nothing comparable since the round — shown at its later-stage round, Apr 2025 ($382.5M post-money).
- ·7 fund marks: filer, period, implied $/share
Membership and data by Private Market View
Valuation timeline
0 priced rounds · 32 daily marks since · Sep 2026 – Oct 2026Membership and data by Private Market View
CellCentric funding history
2 rounds| Date | Round | Raised | Post-money | $/share |
|---|---|---|---|---|
| Apr 2025 | Later Stage VC (Series C) | $116.5M | ▮ | ▮ |
| Jul 2024 | Later Stage VC (Series B) | $35.5M | ▮ | ▮ |
Membership and data by Private Market View
CellCentric valuation
CellCentric is valued at approximately $382 million as of Oct 2026. The figure is set by institutional fund marks. The reference point is its later-stage round in Apr 2025, at a $382 million post-money valuation.
Recent activity
In the last 90 days, CellCentric's record added 4 institutional fund marks (latest period Jul 2026).
How much has CellCentric raised?
CellCentric has raised $281 million in total; 2 of its rounds are on record. The largest on record was a $35.5 million Series B in Jul 2024; the most recent was an $116 million Series C in Apr 2025.
Institutional holders and vehicles
4 SEC-registered funds reported 7 fair-value marks on CellCentric between May 2026 and Jul 2026, in their N-PORT filings. Filer-level marks and implied per-share values are available to Pro members.
Comparable companies
Comparable biotechnology names by valuation on PrivateMarketView: Profluent ($525 million), Checkerspot ($347 million) and Ansa Biotechnologies ($269 million).
How CellCentric's valuation is determined
Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.
For CellCentric, the most current credible signal sets the number and the older ones confirm it: a live secondary-market price first, then three or more recent prints, then institutional fund marks, and otherwise the last priced round, which never decays. The valuation is the last round’s post-money moved by the price change since that round, so no share count is assumed. Today it is set by institutional fund marks. Question about this number? Full methodology →
Frequently asked about CellCentric
- What is CellCentric worth?
- CellCentric is valued at $382.5M as of Oct 2026. Nothing comparable since the round — shown at its later-stage round, Apr 2025 ($382.5M post-money).
- How much has CellCentric raised?
- CellCentric has raised $280.5M in total funding across 2 recorded rounds.
- When did CellCentric last raise?
- CellCentric last raised in Apr 2025 (Later Stage VC (Series C)), raising $116.5M.